European Union · Report · CC
CELEX 62001CC0106
Opinion of Mr Advocate General Jacobs delivered on 23 January 2003.#The Queen, on the application of Novartis Pharmaceuticals UK Ltd v The Licensing Authority established by the Medicines Act 1968 (acting by the Medicines Control Agency).#Reference for a preliminary ruling: Court of Appeal (England and Wales) (Civil Division) - United Kingdom.#Medicinal products - Marketing authorisation - Procedure relating to essentially similar products.#Case C-106/01.
Original
Introduced
23 January 2003
Last action
23 January 2003 · Decided
Status
decided
Sponsors
—
Subjects
Discovery layer
Source updated
23 January 2003
Record
Official report CELEX 62001CC0106 from European Union at Court of Justice of the European Union. Dated 23 January 2003. Status: decided.
Timeline
23 January 2003
Decided
Source: work_date_document
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
23 official files
Opinion of Mr Advocate General Jacobs delivered on 23 January 2003.#The Queen, on the application of Novartis Pharmaceuticals UK Ltd v The Licensing Authority established by the Medicines Act 1968 (acting by the Medicines Control Agency).#Reference for a preliminary ruling: Court of Appeal (England and Wales) (Civil Division) - United Kingdom.#Medicinal products - Marketing authorisation - Procedure relating to essentially similar products.#Case C-106/01.
judgment · EN · 23 January 2003
Jacobs főtanácsnok indítványa, az ismertetés napja: 2003. január 23.#The Queen, kérelme alapján Novartis Pharmaceuticals UK Ltd kérelmére kontra The Licensing Authority established by the Medicines Act 1968 (képviseli:The Medicines Control Agency).#Előzetes döntéshozatal iránti kérelem: Court of Appeal (England and Wales) (Civil Division) - Egyesült Királyság.#C-106/01. sz. ügy.
judgment · HU · 23 January 2003
Mišljenje nezavisnog odvjetnika Jacobs iznesen23. siječnja 2003.#The Queen, na zahtjev Novartis Pharmaceuticals UK Ltd protiv The Licensing Authority established by the Medicines Act 1968 (koje predstavlja The Medicines Control Agency).#Zahtjev za prethodnu odluku: Court of Appeal (England and Wales) (Civil Division) - Ujedinjena Kraljevina.#Predmet C-106/01.
judgment · HR · 23 January 2003
Заключение на генералния адвокат Jacobs представено на23 януари 2003 г.#The Queen, по искане на. Novartis Pharmaceuticals UK Ltd срещу The Licensing Authority established by the Medicines Act 1968 представители The Medicines Control Agency.#Искане за преюдициално заключение: Court of Appeal (England and Wales) (Civil Division) - Обединеното кралство.#Дело C-106/01.
judgment · BG · 23 January 2003
Návrhy generálneho advokáta - Jacobs - 23. januára 2003.#The Queen, na návrh Novartis Pharmaceuticals UK Ltd proti The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Návrh na začatie prejudiciálneho konania Court of Appeal (England and Wales) (Civil Division) - Spojené kráľovstvo.#Vec C-106/01.
judgment · SK · 23 January 2003
Generalinio advokato F. G. Jacobs išvada, pateikta 2003 m. sausio 23 d.#The Queen, prašoma Novartis Pharmaceuticals UK Ltd prašymu, prieš The Licensing Authority established by the Medicines Act 1968 (atstovaujamą The Medicines Control Agency).#Court of Appeal (England and Wales) (Civil Division) (Jungtinė Karalystė) prašymas priimti prejudicinį sprendimą.#Byla C-106/01.
judgment · LT · 23 January 2003
Förslag till avgörande av generaladvokat Jacobs föredraget den 23 januari 2003.#The Queen, på begäran av Novartis Pharmaceuticals UK Ltd mot The Licensing Authority established by the Medicines Act 1968 (företrädd av The Medicines Control Agency).#Begäran om förhandsavgörande: Court of Appeal (England and Wales) (Civil Division) - Förenade kungariket.#Läkemedel - Godkännande för försäljning - Förfarande avseende produkter som i allt väsentligt överensstämmer med varandra.#Mål C-106/01.
judgment · SV · 23 January 2003
Conclusioni dell'avvocato generale Jacobs del 23 gennaio 2003.#The Queen, su richiesta della Novartis Pharmaceuticals UK Ltd contro The Licensing Authority established by the Medicines Act 1968 (rappresentata da The Medicines Control Agency).#Domanda di pronuncia pregiudiziale: Court of Appeal (England and Wales) (Civil Division) - Regno Unito.#Medicinali - Autorizzazione all'immissione in commercio - Procedura relativa a prodotti essenzialmente simili.#Causa C-106/01.
judgment · IT · 23 January 2003
Stanovisko generálního advokáta - Jacobs - 23 ledna 2003.#The Queen, na žádost Novartis Pharmaceuticals UK Ltd proti The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Žádost o rozhodnutí o předběžné otázce: Court of Appeal (England and Wales) (Civil Division) - Spojené království.#Věc C-106/01.
judgment · CS · 23 January 2003
Conclusiones del Abogado General Jacobs presentadas el 23 de enero de 2003.#The Queen, a instancia de Novartis Pharmaceuticals UK Ltd contra The Licensing Authority established by the Medicines Act 1968 (representada por The Medicines Control Agency).#Petición de decisión prejudicial: Court of Appeal (England and Wales) (Civil Division) - Reino Unido.#Medicamentos - Autorización de comercialización - Procedimiento relativo a productos esencialmente similares.#Asunto C-106/01.
judgment · ES · 23 January 2003
Opinia rzecznika generalnego Jacobs przedstawione w dniu 23 stycznia 2003 r.#The Queen, na wniosek Novartis Pharmaceuticals UK Ltd przeciwko The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Wniosek o wydanie orzeczenia w trybie prejudycjalnym: Court of Appeal (England and Wales) (Civil Division) - Zjednoczone Królestwo.#Sprawa C-106/01.
judgment · PL · 23 January 2003
Ģenerāladvokāta Jacobs secinājumi, sniegti 2003. gada 23.janvārī.#The Queen, ko lūdza Novartis Pharmaceuticals UK Ltd pret The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Lūgums sniegt prejudiciālu nolēmumu: Court of Appeal (England and Wales) (Civil Division) - Apvienotā Karaliste.#.#Lieta C-106/01.
judgment · LV · 23 January 2003
Kohtujuristi ettepanek - Jacobs - 23. jaanuar 2003.#The Queen, taotluse alusel, mille esitasid Novartis Pharmaceuticals UK Ltd taotlusel versus The Licensing Authority established by the Medicines Act 1968 (keda esindas The Medicines Control Agency).#Eelotsusetaotlus: Court of Appeal (England and Wales) (Civil Division) - Ühendkuningriik.#Kohtuasi C-106/01.
judgment · ET · 23 January 2003
Konklużjonijiet ta' l-Avukat Ġenerali - Jacobs - 23 ta' Jannar 2003.#The Queen, fuq talba ta' Novartis Pharmaceuticals UK Ltd vs The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Talba għal deċiżjoni preliminari: Court of Appeal (England and Wales) (Civil Division) - ir-Renju Unit.#Kawża C-106/01.
judgment · MT · 23 January 2003
Conclusie van advocaat-generaal Jacobs van 23 januari 2003.#The Queen, op verzoek van Novartis Pharmaceuticals UK Ltd tegen The Licensing Authority established by the Medicines Act 1968 (vertegenwoordigd door The Medicines Control Agency).#Verzoek om een prejudiciële beslissing: Court of Appeal (England and Wales) (Civil Division) - Verenigd Koninkrijk.#Geneesmiddelen - Vergunning voor het in de handel brengen - Procedure voor in wezen gelijkwaardige geneesmiddelen.#Zaak C-106/01.
judgment · NL · 23 January 2003
Conclusões do advogado-geral Jacobs apresentadas em 23 de Janeiro de 2003.#The Queen, a pedido da Novartis Pharmaceuticals UK Ltd contra The Licensing Authority established by the Medicines Act 1968 (representada por The Medicines Control Agency).#Pedido de decisão prejudicial: Court of Appeal (England and Wales) (Civil Division) - Reino Unido.#Medicamentos - Autorização de colocação no mercado - Processo relativo a produtos essencialmente similares.#Processo C-106/01.
judgment · PT · 23 January 2003
Προτάσεις του γενικού εισαγγελέα Jacobs της 23ης Ιανουαρίου 2003.#The Queen, κατόπιν αιτήσεως της Novartis Pharmaceuticals UK Ltd κατά The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Αίτηση για την έκδοση προδικαστικής αποφάσεως: Court of Appeal (England and Wales) (Civil Division) - Ηνωμένο Βασίλειο.#Φάρμακα - Άδεια κυκλοφορίας - Διαδικασία σχετική με ουσιαστικώς παρεμφερή προϊόντα.#Υπόθεση C-106/01.
judgment · EL · 23 January 2003
Sklepni predlogi generalnega pravobranilca - Jacobs - 23. januarja 2003.#The Queen, na predlog Novartis Pharmaceuticals UK Ltd proti The Licensing Authority established by the Medicines Act 1968 (ki jo zastopa The Medicines Control Agency).#Predlog za sprejetje predhodne odločbe: Court of Appeal (England and Wales) (Civil Division) - Združeno kraljestvo.#Zadeva C-106/01.
judgment · SL · 23 January 2003
Julkisasiamiehen ratkaisuehdotus Jacobs 23 päivänä tammikuuta 2003.#The Queen, seuraavien hakemuksesta Novartis Pharmaceuticals UK Ltd: hakemuksesta, vastaan The Licensing Authority established by the Medicines Act 1968 (edustajanaan Medicines Control Agency).#Ennakkoratkaisupyyntö: Court of Appeal (England and Wales) (Civil Division) - Yhdistynyt kuningaskunta.#Lääkkeet - Markkinoille saattamista koskeva lupa - Olennaisilta osiltaan samanlaisia tuotteita koskeva menettely.#Asia C-106/01.
judgment · FI · 23 January 2003
Forslag til afgørelse fra generaladvokat Jacobs fremsat den 23. januar 2003.#The Queen, efter begæring af Novartis Pharmaceuticals UK Ltd mod The Licensing Authority established by the Medicines Act 1968 (ved The Medicines Control Agency).#Anmodning om præjudiciel afgørelse: Court of Appeal (England and Wales) (Civil Division) - Forenede Kongerige.#Lægemidler - markedsføringstilladelse - procedure vedrørende produkter, der i det væsentlige svarer til hinanden.#Sag C-106/01.
judgment · DA · 23 January 2003
Conclusions de l'avocat général Jacobs présentées le 23 janvier 2003.#The Queen, à la demande de Novartis Pharmaceuticals UK Ltd contre The Licensing Authority established by the Medicines Act 1968 (représentée par The Medicines Control Agency).#Demande de décision préjudicielle: Court of Appeal (England and Wales) (Civil Division) - Royaume-Uni.#Médicaments - Autorisation de mise sur le marché - Procédure relative à des produits essentiellement similaires.#Affaire C-106/01.
judgment · FR · 23 January 2003
Schlussanträge des Generalanwalts Jacobs vom 23. Januar 2003.#The Queen, auf Antrag von Novartis Pharmaceuticals UK Ltd gegen The Licensing Authority established by the Medicines Act 1968 (handelnd durch The Medicines Control Agency).#Ersuchen um Vorabentscheidung: Court of Appeal (England and Wales) (Civil Division) - Vereinigtes Königreich.#Arzneimittel - Genehmigung für das Inverkehrbringen - Verfahren für Erzeugnisse, die einander im Wesentlichen gleichen.#Rechtssache C-106/01.
judgment · DE · 23 January 2003
Concluziile avocatului general Jacobs prezentate la data de 23 ianuarie 2003.#The Queen,la cererea formulată de Novartis Pharmaceuticals UK Ltd împotriva The Licensing Authority established by the Medicines Act 1968 reprezentată de The Medicines Control Agency.#Cerere având ca obiect pronunțarea unei hotărâri preliminare: Court of Appeal (England and Wales) (Civil Division) - Regatul Unit.#Cauza C-106/01.
judgment · RO · 23 January 2003
Sponsors
- · CJ · Court of Justice of the European Union
- · 984879ed-1b9c-44b1-9dbe-c8db9bbe2597 · 984879ed-1b9c-44b1-9dbe-c8db9bbe2597
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:62001CC0106
- Open data entity: http://publications.europa.eu/resource/cellar/b9b328ca-c156-4f88-b704-ee8a3aece694
- eurlex · 62001CC0106 · source updated 23 January 2003